All lobbying filings
Brownstein Hyatt Farber Schreck, LLP
Brownstein Hyatt Farber Schreck, LLP filed a Q3 report for Ferring Pharmaceuticals Inc. on October 17, 2026, reporting $50,000 in lobbying income.
Lobbying for Ferring Pharmaceuticals Inc. · biopharmaceutical company
Filing · LD-2 quarterly report
Q3 report
Reporting period
3rd Quarter 2026
July 1 - Sep 30 · Posted Oct 17, 2026
Income
$50,000
What the client paid this registrant for the period.
Client based in
New Jersey
Lobbyists on this filing
2
-
STEPHEN HOLLAND New on this filingPreviously held: Senior Health Counsel, Health Counsel - House Energy and Commerce Committee (Rep. Frank Pallone); Counsel, Legislative Assistant - Rep. Kurt Schrader
-
SARA MORSE New on this filingPreviously held: Principal Deputy Assistant Secretary for Legislation at the Department of Health and Human Services; Deputy Assistant Secretary for Legislation at the Department of Health and Human Services
Government bodies contacted
3
Lobbying activity
3
Issues related to microbiome, oncology, & fertility Issues related to formulary tier status Drug pricing policy Healthcare policy in the NDAA IVF Tax credit FDA Review programs
Issues related to veteran's care and veteran's reproductive care
Issues related to pharmaceutical tariffs